New Enterprise Associates 17, L.P. Insider Profile
4 Followers
New Enterprise Associates 17, L.P., Ten Percent Owner at Monte Rosa Therapeutics, holds 7.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds ― shares in NeueHealth Inc (Ticker: NEUE), holds 3.61M shares in MBX Biosciences, Inc. (Ticker: MBX).
What was New Enterprise Associates 17, L.P.’s latest transaction?
New Enterprise Associates 17, L.P. latest transaction was an Uninformative Buy of ―.
What was New Enterprise Associates 17, L.P.'s most profitable transaction?
New Enterprise Associates 17, L.P.’s most profitable transaction was an Informative Buy of KRRO stock on April 24, 2024. The return on the trade was -34.20%.
What is New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics?
New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.